Skip to main content

Table 3 The binding sites of peptides to HPV-related high-frequency HLA-1 alleles in general population, with VaxiJen antigenicity scores >1

From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45

No

Peptide

Positions

Allele

VaxiJen Score

1

EEYDLQFIF

398–406

HLA-B*40:01

1.7384

2

KLKFWTVDLK

473–482

HLA-A*03:01

1.1434